WAT · Healthcare
What a holder would want to know before buying WAT: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.
Today’s price is 53% above the lowest point of the past year and 2% below the highest.
Over the past year it was cheaper than today on 97% of days and more expensive on 3%. Over the last 10 years: cheaper on more than 99% of days.
19% above its average price of the last 200 trading days.
Fell 20% or more 3 times in 10 years. The deepest fall was 44%; the longest took 5.0 years to get back to its peak. Every one recovered.
Now 2% below the Sep 2026 peak.
Waters Corporation · Healthcare · Diagnostics & Research · a large company worth $42.59B
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid…
revenue profit
Sales of $3.17B in 2025, with $642.63M of profit. Sales grew in 2 of the last 3 years.
Keeps about 4 cents of every dollar of sales as profit.
Free cash flow is negative: the business spends more cash than it brings in, with $539.00M in the bank.
You pay $110 for every $1 of last year’s profit, and $26 for every $1 of profit expected next year.
A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.
Pays no dividend.
24 analysts: 18 say buy, 6 hold, 0 sell. Their average 12-month target is $458.22 (range $349.00–$530.00).
Insiders made 0 purchases and 1 sale in the last 6 months. Executives routinely sell shares they were paid in; buying with their own money is the rarer signal.
Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.
Poshkan is paper trading: real prices, virtual money. Buy WAT with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.
Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.